Of these, the most significantly enriched pathway was “RhoA signaling” (p = 4.59E-03) which incorporates 2 of the mRNA transcripts identified in vaginal melanoma with significantly decreased expression relative to normal vaginal mucosa (ACTG2 and MYL9). The gene discussed is RHOA; the disease is vaginal melanoma.